Trade Summary

6 days ago, Jenkins John Kenneth, serving as Dir at Corbus Pharmaceuticals Holdings, Inc. (CRBP), sold 4,800 shares at $7.91 per share, for a total transaction value of $37,985.76. Following this transaction, Jenkins John Kenneth now holds 3,833 shares of CRBP.

This sale represents a 55.60% decrease in Jenkins John Kenneth's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 11, 2026 at 4:30 PM ET, 1 day after the trade was made.

Corbus Pharmaceuticals Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.